MedTrace Logo

Evaluation of Pupil Dilation Speed With the MAP Dispenser

NCT04907474 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-01-09

Study results available
· View outcomes & findings →

Summary

1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan to determine the effect on pupil dilation

Conditions

  • Mydriasis

Interventions

DRUG

tropicamide-phenylephrine fixed combination ophthalmic solution

Tropicamide-phenylephrine fixed combination ophthalmic solution is a tropical drug solution for mydriasis

Sponsors & Collaborators

  • Eyenovia Inc.

    lead INDUSTRY

Principal Investigators

  • Tsontcho Ianchulev, MD, MPH · Eyenovia Inc.

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-24
Primary Completion
2021-06-03
Completion
2021-06-03

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907474 on ClinicalTrials.gov